| scholarly article | Q13442814 |
| P50 | author | Henry Daniell | Q30533568 |
| P2093 | author name string | Dheeraj Verma | |
| Kwang-Chul Kwon | |||
| Nameirakpam D Singh | |||
| Roland Herzog | |||
| P2860 | cites work | A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India | Q21144301 |
| Mucosal administration of alpha-fodrin inhibits experimental Sjögren's syndrome autoimmunity | Q21195405 | ||
| Oral vaccines for preventing cholera | Q24235775 | ||
| Molecular strategies for gene containment in transgenic crops | Q24629294 | ||
| Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection | Q28744570 | ||
| Differentiation of effector CD4 T cell populations (*) | Q29614838 | ||
| Yersinia pestis--etiologic agent of plague | Q29619320 | ||
| Peptide drugs to target G protein-coupled receptors | Q37775230 | ||
| Progress towards a needle-free hepatitis B vaccine | Q37810816 | ||
| Cytokines: the future of intranasal vaccine adjuvants. | Q37914007 | ||
| Delivery of plant-made vaccines and therapeutics. | Q37917905 | ||
| Oral biodrug delivery using cell-penetrating peptide | Q37975835 | ||
| Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice. | Q37977140 | ||
| Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation. | Q38006994 | ||
| Immunogenicity of Plasmodium yoelii merozoite surface protein 4/5 produced in transgenic plants | Q38447138 | ||
| Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts | Q39118535 | ||
| Impact of the underlying mutation and the route of vector administration on immune responses to factor IX in gene therapy for hemophilia B. | Q39501844 | ||
| Antibodies against the Plasmodium falciparum receptor binding domain of EBA-175 block invasion pathways that do not involve sialic acids | Q39515040 | ||
| Design and in vitro characterization of buccoadhesive drug delivery system of insulin | Q39963004 | ||
| Protection of NOD mice from type 1 diabetes after oral inoculation with vaccinia viruses expressing adjuvanted islet autoantigens | Q40382880 | ||
| Cell surface phenotype and cytokine secretion in Caco-2 cell cultures: increased RANTES production and IL-2 transcription upon stimulation with IL-1beta | Q40752890 | ||
| Lens culinaris, Phaseolus vulgaris and vicia faba lectins specifically trigger IL-8 production by the human colon carcinoma cell line CACO-2. | Q40863802 | ||
| Antigen sampling across epithelial barriers and induction of mucosal immune responses | Q41039707 | ||
| Nasal delivery of vaccines | Q41156926 | ||
| A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague | Q41440200 | ||
| The fraction 1 and V protein antigens of Yersinia pestis activate dendritic cells to induce primary T cell responses | Q41447968 | ||
| A plant-produced plague vaccine candidate confers protection to monkeys | Q41450225 | ||
| A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model | Q41493178 | ||
| Bioencapsulation of the hepatitis B surface antigen and its use as an effective oral immunogen | Q41869849 | ||
| Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts | Q41947780 | ||
| Manipulation of intestinal immune responses against ovalbumin by cholera toxin and its B subunit in mice | Q41961871 | ||
| Vaccines against gut pathogens | Q41966350 | ||
| Oral administration of a cholera toxin B subunit-insulin fusion protein produced in silkworm protects against autoimmune diabetes | Q42040362 | ||
| Surface area of the small intestine in man | Q42046709 | ||
| Polyvalent DNA prime and envelope protein boost HIV-1 vaccine elicits humoral and cellular responses and controls plasma viremia in rhesus macaques following rectal challenge with an R5 SHIV isolate | Q42054413 | ||
| Altered B:9-23 insulin, when administered intranasally with cholera toxin adjuvant, suppresses the expression of insulin autoantibodies and prevents diabetes | Q80736018 | ||
| Exenatide | Q81247842 | ||
| Mucosal administration of an altered CII263-272 peptide inhibits collagen-induced arthritis by suppression of Th1/Th17 cells and expansion of regulatory T cells | Q81578108 | ||
| Mucosal immunization using recombinant plant-based oral vaccines | Q82345610 | ||
| Pfizer stakes a claim in plant cell-made biopharmaceuticals | Q82821682 | ||
| Prevention of allergic asthma by vaccination with transgenic rice seed expressing mite allergen: induction of allergen-specific oral tolerance without bystander suppression | Q83742158 | ||
| Oral tolerance | Q83849376 | ||
| Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism | Q84081029 | ||
| Immunotherapy of autoimmune diabetes by nasal administration of tandem glutamic acid decarboxylase 65 peptides | Q84791626 | ||
| A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity | Q84826087 | ||
| Overexpression of the Bt cry2Aa2 operon in chloroplasts leads to formation of insecticidal crystals | Q42055155 | ||
| Immune deviation by mucosal antigen administration suppresses gene-transfer-induced inhibitor formation to factor IX. | Q42183295 | ||
| Expression and characterization of antimicrobial peptides Retrocyclin-101 and Protegrin-1 in chloroplasts to control viral and bacterial infections | Q42429984 | ||
| The role of heterologous chloroplast sequence elements in transgene integration and expression | Q43174691 | ||
| Progress towards the development of malaria vaccines | Q43675966 | ||
| Tight junctions form a barrier in human epidermis | Q43803447 | ||
| A New Subunit Influenza Vaccine: Acceptability Compared with Standard Vaccines and Effect of Dose on Antigenicity | Q43881540 | ||
| Effect of sonication parameters on transdermal delivery of insulin to hairless rats. | Q43981385 | ||
| Phospholipid deformable vesicles for buccal delivery of insulin | Q44015111 | ||
| Buccoadhesive tablets for insulin delivery: in-vitro and in-vivo studies. | Q44115560 | ||
| Pathways and strategies for developing a malaria blood-stage vaccine | Q44138781 | ||
| Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine | Q44438134 | ||
| Development of inhibitors in haemophilia. Ongoing epidemiological study | Q44529938 | ||
| Transdermal iontophoresis of insulin: IV. Influence of chemical enhancers | Q44708576 | ||
| Uptake and metabolism of exogenous gangliosides by cultured cells: effect of choleragen on the turnover of GM1. | Q45047566 | ||
| Clinical trial: pharmacodynamics and pharmacokinetics of re-treatment with fixed-dose induction of peginterferon alpha-2a in hepatitis C virus genotype 1 true non-responder patients. | Q45399952 | ||
| Induction of partial immune tolerance to factor VIII through prior mucosal exposure to the factor VIII C2 domain | Q45859514 | ||
| A plant-based cholera toxin B subunit–insulin fusion protein protects against the development of autoimmune diabetes | Q45889680 | ||
| The Immunizing Effect of Influenza A/New Jersey/76 (Hsw1N1) Virus Vaccine Administered Intradermally and Intramuscularly to Adults | Q45890359 | ||
| The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery. | Q45916817 | ||
| Efficient induction of oral tolerance by fusing cholera toxin B subunit with allergen-specific T-cell epitopes accumulated in rice seed | Q46342747 | ||
| Nasal delivery of insulin using chitosan microspheres | Q46411846 | ||
| Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat. | Q46425984 | ||
| Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea | Q46458866 | ||
| Preparation and evaluation of chitosan-ethylenediaminetetraacetic acid hydrogel films for the mucoadhesive transbuccal delivery of insulin | Q46597054 | ||
| Nasal delivery of insulin using bioadhesive chitosan gels | Q46886042 | ||
| Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease | Q47346480 | ||
| Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato | Q47614578 | ||
| The role of ADP‐ribosylation and GM1‐binding activity in the mucosal immunogenicity and adjuvanticity of the Escherichia coli heat‐labile enterotoxin and Vibrio cholerae cholera toxin | Q47771715 | ||
| Immune response of infants to fractional doses of intradermally administered inactivated poliovirus vaccine | Q47773752 | ||
| Insulin-micro- and nanoparticles for pulmonary delivery | Q47788713 | ||
| Malaria: the end of the beginning | Q47861712 | ||
| A phase 1 trial of PfCP2.9: an AMA1/MSP1 chimeric recombinant protein vaccine for Plasmodium falciparum malaria | Q47885076 | ||
| Immunogenicity and protective efficacy of Escherichia coli expressed Plasmodium falciparum merozoite surface protein-1(42) using human compatible adjuvants | Q48021487 | ||
| Nasal drug delivery | Q48291849 | ||
| Remodeling the isoprenoid pathway in tobacco by expressing the cytoplasmic mevalonate pathway in chloroplasts | Q49522968 | ||
| Characterization of heterologous multigene operons in transgenic chloroplasts: transcription, processing, and translation | Q51421888 | ||
| Expression of the cholera toxin B subunit (CT-B) in maize seeds and a combined mucosal treatment against cholera and traveler’s diarrhea | Q54352501 | ||
| Malaria | Q55878749 | ||
| Drawing lithography: three-dimensional fabrication of an ultrahigh-aspect-ratio microneedle | Q57154601 | ||
| Immunogenicity of a plant-derived edible chimeric EspA, Intimin and Tir of Escherichia coli O157:H7 in mice | Q59274678 | ||
| Haemophilia B: impact on patients and economic burden of disease | Q64041202 | ||
| General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) | Q64129678 | ||
| Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response | Q70591810 | ||
| Monomer of the B subunit of heat-labile enterotoxin from enterotoxigenic Escherichia coli has little ability to bind to GM1 ganglioside compared to its coligenoid | Q70940365 | ||
| Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance | Q73486424 | ||
| Human nasal mucosa contains antigen-presenting cells of strikingly different functional phenotypes | Q73581449 | ||
| Cell surface phenotype and ultramicroscopic analysis of purified human enterocytes: a possible antigen-presenting cell in the intestine | Q74150936 | ||
| Study on a nanoparticle system for buccal delivery of insulin | Q79727645 | ||
| Insulin as an autoantigen in NOD/human diabetes | Q36499414 | ||
| Oral delivery of bioencapsulated exendin-4 expressed in chloroplasts lowers blood glucose level in mice and stimulates insulin secretion in beta-TC6 cells | Q36504504 | ||
| Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs | Q36530971 | ||
| Cholera toxin B subunit linked to glutamic acid decarboxylase suppresses dendritic cell maturation and function. | Q36551840 | ||
| Novel delivery technologies for protein and peptide therapeutics | Q36570172 | ||
| Present and future cholera vaccines | Q36690265 | ||
| Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts. | Q36804213 | ||
| Inhibitor development in haemophilia B: an orphan disease in need of attention | Q36872038 | ||
| Current challenges in non-invasive insulin delivery systems: a comparative review | Q36946206 | ||
| Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts--oral administration protects against development of insulitis in non-obese diabetic mice | Q36990434 | ||
| Field production and functional evaluation of chloroplast-derived interferon-alpha2b | Q37000665 | ||
| Chloroplast vector systems for biotechnology applications | Q37023309 | ||
| Albinterferon alpha-2b: a genetic fusion protein for the treatment of chronic hepatitis C. | Q37027164 | ||
| Apical membrane antigen 1: a malaria vaccine candidate in review | Q37069649 | ||
| Cholera vaccines for the developing world. | Q37138956 | ||
| Optimization of codon composition and regulatory elements for expression of human insulin like growth factor-1 in transgenic chloroplasts and evaluation of structural identity and function | Q37182165 | ||
| Transdermal drug delivery | Q37238479 | ||
| Barrier properties of mucus | Q37365829 | ||
| Immune response to FVIII in hemophilia A: an overview of risk factors | Q37370005 | ||
| Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedles | Q37426334 | ||
| Infections and autoimmunity--friends or foes? | Q37567077 | ||
| Plant-made vaccine antigens and biopharmaceuticals | Q37616370 | ||
| Prevention of bubonic and pneumonic plague using plant-derived vaccines | Q37636760 | ||
| Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit | Q37657673 | ||
| Induction of oral tolerance to prevent diabetes with transgenic plants requires glutamic acid decarboxylase (GAD) and IL-4. | Q37682917 | ||
| Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice | Q30402980 | ||
| Stable expression of Gal/GalNAc lectin of Entamoeba histolytica in transgenic chloroplasts and immunogenicity in mice towards vaccine development for amoebiasis | Q30424547 | ||
| Hypoglycaemic effect of a novel insulin buccal formulation on rabbits | Q30868752 | ||
| Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo | Q31045989 | ||
| Discovering and improving novel peptide therapeutics | Q33349255 | ||
| Investigation on the synergistic effect of a combination of chemical enhancers and modulated iontophoresis for transdermal delivery of insulin | Q33545395 | ||
| The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites | Q33558061 | ||
| Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery | Q33596284 | ||
| Immunotherapy of type 1 diabetes: where are we and where should we be going? | Q33815506 | ||
| Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice | Q33859520 | ||
| The NOD mouse model of type 1 diabetes: as good as it gets? | Q33865111 | ||
| Modulation of immune responses following antigen administration by mucosal route | Q33869471 | ||
| Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense | Q33901607 | ||
| Evolving trends in insulin delivery in pursuit of improvements in diabetes management | Q33932057 | ||
| Collaboration of epithelial cells with organized mucosal lymphoid tissues. | Q33955758 | ||
| Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). | Q33989220 | ||
| C-peptide is a bioactive peptide | Q34002043 | ||
| Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys | Q34003578 | ||
| Specificity of the protective antibody response to apical membrane antigen 1 | Q34007362 | ||
| Cholera toxin - a foe & a friend. | Q34026162 | ||
| A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses | Q34161016 | ||
| Factors and strategies for improving buccal absorption of peptides. | Q34167000 | ||
| Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge | Q34194628 | ||
| Mapping the T helper cell response to acid α-glucosidase in Pompe mice | Q34228856 | ||
| Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge | Q34244892 | ||
| Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system | Q34250117 | ||
| Vaccination against bubonic and pneumonic plague | Q34310210 | ||
| Overcoming skin's barrier: the search for effective and user-friendly drug delivery | Q34322370 | ||
| Robust recall and long-term memory T-cell responses induced by prime-boost regimens with heterologous live viral vectors expressing human immunodeficiency virus type 1 Gag and Env proteins | Q34343020 | ||
| A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis. | Q34343581 | ||
| Mucosal immunity and vaccines | Q34409172 | ||
| The pancreas in human type 1 diabetes | Q34496850 | ||
| Protein transduction technology | Q34534961 | ||
| Metallothionein expression in chloroplasts enhances mercury accumulation and phytoremediation capability | Q34628765 | ||
| Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit. | Q34629092 | ||
| A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants | Q34678990 | ||
| Bioreducible polymers for gene delivery | Q34812807 | ||
| The role of incretins in glucose homeostasis and diabetes treatment | Q34901533 | ||
| The immune geography of IgA induction and function | Q34903056 | ||
| Interaction of cholera toxin and membrane GM1 ganglioside of small intestine | Q35083242 | ||
| TH1-TH2: a procrustean paradigm | Q35139852 | ||
| Curbing activation: proprotein convertases in homeostasis and pathology | Q35165457 | ||
| A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria. | Q35463512 | ||
| Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii | Q35551948 | ||
| Recovery of skin barrier after stratum corneum removal by microdermabrasion | Q35577226 | ||
| Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes | Q35618856 | ||
| Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses | Q35672048 | ||
| Transgene containment by maternal inheritance: effective or elusive? | Q35758721 | ||
| Immune therapy for autoimmune diseases | Q35833158 | ||
| Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination | Q35865115 | ||
| The mucosal immune system: from fundamental concepts to vaccine development | Q35897681 | ||
| Clinical utility gene card for: haemophilia B. | Q35899385 | ||
| Novel approaches to vaccine delivery | Q35924680 | ||
| Chloroplast-derived vaccine antigens and other therapeutic proteins | Q36055964 | ||
| Mucosal adjuvants | Q36055990 | ||
| Towards an effective malaria vaccine | Q36121709 | ||
| Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment | Q36338254 | ||
| Low-cost production of proinsulin in tobacco and lettuce chloroplasts for injectable or oral delivery of functional insulin and C-peptide | Q36344923 | ||
| Expression of Bacillus anthracis protective antigen in transgenic chloroplasts of tobacco, a non-food/feed crop | Q36349402 | ||
| Receptor-mediated oral delivery of a bioencapsulated green fluorescent protein expressed in transgenic chloroplasts into the mouse circulatory system | Q36349444 | ||
| Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites | Q36349656 | ||
| A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. | Q36352078 | ||
| Mucosal vaccines: the promise and the challenge | Q36402244 | ||
| Strategies to improve plasma half life time of peptide and protein drugs | Q36452632 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vaccine | Q134808 |
| P304 | page(s) | 782-799 | |
| P577 | publication date | 2012-10-23 | |
| P1433 | published in | Advanced Drug Delivery Reviews | Q2825362 |
| P1476 | title | Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells | |
| P478 | volume | 65 |
| Q59335426 | A Preliminary Study of a Lettuce-Based Edible Vaccine Expressing the Cysteine Proteinase of for Fasciolosis Control in Livestock |
| Q38285790 | Activation of human mast cells by retrocyclin and protegrin highlight their immunomodulatory and antimicrobial properties |
| Q21131110 | Algae-based oral recombinant vaccines |
| Q38356275 | An overview of tuberculosis plant-derived vaccines |
| Q89944637 | Autoantigen Treatment in Type 1 Diabetes: Unsolved Questions on How to Select Autoantigen and Administration Route |
| Q70909584 | Biopharmaceutical benchmarks 2014 |
| Q26800266 | Bringing plant-based veterinary vaccines to market: Managing regulatory and commercial hurdles |
| Q38527379 | Chikungunya virus vaccines: Current strategies and prospects for developing plant-made vaccines. |
| Q34777770 | Cloning and Expression of TNF Related Apoptosis Inducing Ligand in Nicotiana tabacum |
| Q37324787 | Cold chain and virus-free chloroplast-made booster vaccine to confer immunity against different poliovirus serotypes |
| Q38545125 | Current Developments and Future Prospects for Plant-Made Biopharmaceuticals Against Rabies |
| Q38307990 | Current status of viral expression systems in plants and perspectives for oral vaccines development |
| Q55040904 | Design of a Type-1 Diabetes Vaccine Candidate Using Edible Plants Expressing a Major Autoantigen. |
| Q36936276 | Design of pH-Responsive Biomaterials to Enable the Oral Route of Hematological Factor IX |
| Q38177668 | Developing inexpensive malaria vaccines from plants and algae |
| Q57816705 | Development of Adjuvant-Free Bivalent Food Poisoning Vaccine by Augmenting the Antigenicity of Enterotoxin |
| Q38796221 | Edible plants for oral delivery of biopharmaceuticals. |
| Q35909883 | Engineered chloroplast dsRNA silences cytochrome p450 monooxygenase, V-ATPase and chitin synthase genes in the insect gut and disrupts Helicoverpa armigera larval development and pupation |
| Q45874015 | Expression and assembly of largest foreign protein in chloroplasts: oral delivery of human FVIII made in lettuce chloroplasts robustly suppresses inhibitor formation in haemophilia A mice. |
| Q36396478 | Expression of the Multimeric and Highly Immunogenic Brucella spp. Lumazine Synthase Fused to Bovine Rotavirus VP8d as a Scaffold for Antigen Production in Tobacco Chloroplasts. |
| Q36619308 | Expression of β-glucosidase increases trichome density and artemisinin content in transgenic Artemisia annua plants |
| Q37620820 | From gut to brain: bioencapsulated therapeutic protein reduces amyloid load upon oral delivery |
| Q30393213 | How can plant genetic engineering contribute to cost-effective fish vaccine development for promoting sustainable aquaculture? |
| Q38574966 | In vivo induction of regulatory T cells for immune tolerance in hemophilia |
| Q34380850 | Inhibitors - cellular aspects and novel approaches for tolerance |
| Q38894155 | Innovating immune tolerance induction for haemophilia. |
| Q38728810 | Lettuce-produced hepatitis C virus E1E2 heterodimer triggers immune responses in mice and antibody production after oral vaccination. |
| Q36445623 | Low cost delivery of proteins bioencapsulated in plant cells to human non-immune or immune modulatory cells. |
| Q36037525 | Low cost industrial production of coagulation factor IX bioencapsulated in lettuce cells for oral tolerance induction in hemophilia B. |
| Q34565122 | Low cost tuberculosis vaccine antigens in capsules: expression in chloroplasts, bio-encapsulation, stability and functional evaluation in vitro |
| Q38543395 | Modification of drug delivery to improve antibiotic targeting to the stomach. |
| Q38727453 | Mucosal vaccine delivery: Current state and a pediatric perspective |
| Q63740220 | Novel approaches for the design, delivery and administration of vaccine technologies |
| Q89391466 | Novel nanocarrier for oral Hepatitis B vaccine |
| Q35002326 | On the way to commercializing plant cell culture platform for biopharmaceuticals: present status and prospect |
| Q28079063 | Oral Delivery of Protein Drugs Bioencapsulated in Plant Cells |
| Q92608280 | Oral Immunization with Soybean Storage Protein Containing Amyloid-β 4-10 Prevents Spatial Learning Decline |
| Q45864205 | Oral Tolerance Induction in Hemophilia B Dogs Fed with Transplastomic Lettuce |
| Q51372211 | Oral Vaccine Development by Molecular Display Methods Using Microbial Cells |
| Q40609980 | Oral delivery of ACE2/Ang-(1-7) bioencapsulated in plant cells protects against experimental uveitis and autoimmune uveoretinitis. |
| Q36083396 | Oral delivery of Acid Alpha Glucosidase epitopes expressed in plant chloroplasts suppresses antibody formation in treatment of Pompe mice |
| Q30600509 | Oral delivery of Angiotensin-converting enzyme 2 and Angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension. |
| Q37620814 | Oral delivery of bioencapsulated proteins across blood-brain and blood-retinal barriers |
| Q36582796 | Oral-tolerization Prevents Immune Responses and Improves Transgene Persistence Following Gene Transfer Mediated by Adeno-associated Viral Vector |
| Q48180883 | Phaseolin expression in tobacco chloroplast reveals an autoregulatory mechanism in heterologous protein translation |
| Q41365905 | Plant-based oral delivery of β-glucocerebrosidase as an enzyme replacement therapy for Gaucher's disease |
| Q35348677 | Plant-based oral tolerance to hemophilia therapy employs a complex immune regulatory response including LAP+CD4+ T cells |
| Q26738581 | Plant-based oral vaccines against zoonotic and non-zoonotic diseases |
| Q37638227 | Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice |
| Q26783111 | Plant-made oral vaccines against human infectious diseases-Are we there yet? |
| Q90713910 | Production of tetravalent dengue virus envelope protein domain III based antigens in lettuce chloroplasts and immunologic analysis for future oral vaccine development |
| Q37835406 | Progress and future opportunities in the development of vaccines against atherosclerosis |
| Q38090391 | Progress toward inducing immunologic tolerance to factor VIII |
| Q39154043 | Recent advances in hemophilia B therapy |
| Q38534952 | Rice seed for delivery of vaccines to gut mucosal immune tissues |
| Q90668573 | State of research in the field of the creation of plant vaccines for veterinary use |
| Q34137024 | Suppression of inhibitor formation against FVIII in a murine model of hemophilia A by oral delivery of antigens bioencapsulated in plant cells |
| Q26781748 | The Engineered Chloroplast Genome Just Got Smarter |
| Q38314279 | The increasing value of plant-made proteins. |
| Q92600927 | The potential of plant systems to break the HIV-TB link |
| Q41819296 | Topical delivery of low-cost protein drug candidates made in chloroplasts for biofilm disruption and uptake by oral epithelial cells |
| Q35530615 | Transgenic carrot expressing fusion protein comprising M. tuberculosis antigens induces immune response in mice |
| Q38243438 | Transgenic plants: a 5-year update on oral antipathogen vaccine development |
| Q52765610 | Transplastomic Nicotiana benthamiana plants expressing multiple defence genes encoding protease inhibitors and chitinase display broad-spectrum resistance against insects, pathogens and abiotic stresses |
| Q33870122 | Vaccination via Chloroplast Genetics: Affordable Protein Drugs for the Prevention and Treatment of Inherited or Infectious Human Diseases |
Search more.